OptrumRx

OptrumRx, To Keep AbbVie’s Humira 3 Others On Its Formulary In 2023

According to a Bloomberg report, OptrumRx, UnitedHealth’s pharmacy benefit manager, will keep AbbVie’s best-selling rheumatoid arthritis drug Humira on its formulary…